Evidence map›Paper›PMID 35791100›Full record

SynthesisIndian journal of ophthalmology2022

Ophthalmic registries for rare eye diseases.

Mohita Sharma, Neha Jain, Vibha Singh, Silkee Singla, Insha Aftab

Open access · diamondAbstract readSystematic Review
In one paragraph

Synthesis in Indian journal of ophthalmology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Comments on: Ophthalmic registries for rare eye diseases.Indian journal of ophthalmology · 2023
    Article
  3. Commentary: Rare eye diseases: More than meets the eye!Indian journal of ophthalmology · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Mohita SharmaDepartment of Ophthalmology, Tirupati Eye Centre, Noida, Uttar Pradesh, India.
Neha JainThe Cornea Institute, KAR Campus, LV Prasad Eye Institute, Hyderabad, Telangana, India.
Vibha SinghDepartment of Ophthalmology, Tirupati Eye Centre, Noida, Uttar Pradesh, India.
Silkee SinglaDepartment of Ophthalmology, Tirupati Eye Centre, Noida, Uttar Pradesh, India.
Insha AftabDepartment of Ophthalmology, Tirupati Eye Centre, Noida, Uttar Pradesh, India.
L V Prasad Eye Institute · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prevalence of rare diseases has been estimated to be around 6%-8%, most of which are genetic in origin. Rare eye diseases constitute a critical public health concern. The major concerns for people suffering from these conditions are diagnosis, treatment, rehabilitation, limited resources, and health infrastructure. Also, as the number of people suffering from these disorders is less, it becomes difficult to study the epidemiological distribution and natural course of the disease. Thus, there is a need to establish registries for such rare disorders. This will help in creating a database of those suffering from rare eye diseases and will prove advantageous for both the patients and the researchers. For patients, it will be helpful as it will provide them will access to families suffering from similar problems, provide rehabilitation services, and provide access to clinical trials working on the development of new treatments for these rare disorders. From the researchers' point of view, it will be beneficial for them as they will then have access to a pool of data that can be used as a starting point of research on these rare disorders. At present, very few registries exist around the world and none in India. A systematic review of registries for rare eye diseases on Google and PubMed was done for existing registries, their methodology, services provided, applications, and advantages.

Indexed as

Eye DiseasesRare DiseasesHumansIndiaPublic HealthRegistriesDatabaseIndiaophthalmic registriesrare eye diseasesresearch and clinical trials

Identifiers

PMID35791100
PMCPMC9426202
OpenAlexW4284705196

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.